Clinical Trials
29 trialsBrodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Unity Health Toronto
iCaRe2
University of Nebraska
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Orano Med LLC
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Aurigene Discovery Technologies Limited
PSI-Immune
University of Pittsburgh
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
(CLOCS-2)
Imperial College London
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor, Inc.
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
MBrace Therapeutics
Improving Care for Rural Patients With Solid Tumors
University of Colorado, Denver
ID-COMET
Roswell Park Cancer Institute
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering Cancer Center
VARTUTRACE
Var2 Pharmaceuticals
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
EXCEL
University of Calgary
DENALI-1
A2 Biotherapeutics Inc.
RCT-SE
Centre Hospitalier de Valence
SPARTA
Apollomics Inc.
COST-FIN
Northwestern University
OligoRARE
European Organisation for Research and Treatment of Cancer - EORTC
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
EXCEL
University of Calgary